Personalized assessment of platelet function Understanding a patient’s true platelet function can provide insight into the risk of bleeding and greater confidence in therapeutic decisions. The TEG PlateletMapping assay overcomes the limitations of thrombin generated viscoelastic testing to reliably The TEG hemostasis analyzer and PlateletMapping assay provides valuable information to help you answer: ■■ How is the patient’s platelet function responding to their anti-platelet therapy? platelets to participate in clot formation, What is the effect on coagulation? with and without the effect of anti-platelet What is their risk of bleeding during surgery? drugs relative to the overall clot strength. What is their risk of thrombotic or ischemic events? and accurately measure the ability of

The TEG® analyzer with PlateletMapping® assay provides a comprehensive view of the patient’s hemostasis to help assess risk and direct therapy. The assay system shows underlying hemostasis — including contribution of coagulation factors to clotting, baseline platelet function, clot breakdown and potential pro-thrombotic qualities—plus receptor-specific platelet function and inhibition. “Percent inhibition” does not tell the full story of bleeding risk Individual patient response to platelet inhibiting drugs has been shown to be variable, with up to 30% of patients on clopidogrel achieving sub-therapeutic...